Outpatient oral anticoagulation in Poland in 2012: A single centre experience

Kardiologia Polska

Volumn 71, Issue 11, 2013, Pages 1135-1139

  Dereziński, Tadeusz ^a   Wasikowska, Beata ^a   Strzebonski, Bartosz ^a   Jawien, Arkadiusz ^b  

^a NZOZ ESCULAP Gniewkowo   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Anticoagulant treatment; Bleeding risk; Primary care; Thrombotic risk; Treatment effectiveness

Indexed keywords

ANTIVITAMIN K;

AGED; ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; POLAND; PRIMARY MEDICAL CARE;

ADMINISTRATION, ORAL; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; CAUSALITY; COMORBIDITY; FEMALE; HEMORRHAGE; HUMANS; MALE; OUTPATIENTS; POLAND; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; THROMBOEMBOLISM; VITAMIN K;

EID: 84888228674     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: 10.5603/KP.2013.0294     Document Type: Article

References (13)

1. van Walraven C, Jennings A, Oake N et al. Effect of study setting on anticoagulation control: a systematic review and metaregression. Chest, 2006; 129: 1155-1166.
2. The European Atrial Fibrillation Trial Study Group. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med, 1995; 333: 5-10.
3. Jones M, McEwan P, Morgan CL et al. Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population. Heart, 2005; 91: 472-477.
4. White HD, Gruber M, Feyzi J et al. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. Arch Intern Med, 2007; 167: 239-245.
5. Torn M, Cannegieter SC, Bollen WL et al. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients. Arch Intern Med, 2009; 169: 1203-1209.
6. Wittkowsky AK, Nutescu EA, Blackburn J et al. Outcomes of oral anticoagulant therapy managed by telephone vs in-office visits in an anticoagulation clinic setting. Chest, 2006; 130: 1385-1389.
7. Siebenhofer A, Berghold A, Sawicki PT. Systematic review of studies of self-management of oral anticoagulation. Thromb Haemost, 2004; 91: 225-232.
8. Gardiner C, Williams K, Mackie IJ et al. Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. Br J Haematol, 2005; 128: 242-247.
9. Matchar DB, Jacobson A, Dolor R et al. THINRS Executive Committee and Site Investigators: effect of home testing of international normalized ratio on clinical events. N Engl J Med, 2010; 363: 1608-1620.
10. Gadisseur AP, Christiansen SC, VAN DER Meer FJ et al. The quality of oral anticoagulant therapy and recurrent venous thrombotic events in the Leiden Thrombophilia Study. J Thromb Haemost, 2007; 5: 931-936.
11. Gurwitz JH, Field TS, Radford MJ et al. The safety of warfarin therapy in the nursing home setting. Am J Med, 2007; 120: 539-544.
12. White HD, Gruber M, Feyzi J et al. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. Arch Intern Med, 2007; 167: 239-245.
13. Oake N, Jennings A, Forster AJ et al. Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis. CMAJ, 2008; 179: 235-244.